Regulatory Reactivity in FDA’s Approval of Aduhelm
A controversial approval of an Alzheimer’s treatment reveals a core weakness in oversight of agency discretion.
Portugal’s Response to COVID-19
Timely and extensive interventions have facilitated Portugal’s success in addressing COVID-19.